Mind Medicine Mindmed Inc (MNMD)

$6.70 -0.04 (-0.59%)
Market Cap 516.78M
Revenue (ttm) 0.00
Net Income (ttm) -108.68M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.10
Volume 219,228
Avg Vol 1,102,868
Day's Range N/A - N/A
Shares Out 75.55M
Stochastic %K 40%
Beta 2.52
Analysts Strong Sell
Price Target $25.00

Company Profile

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is head...

Industry: Biotechnology
Sector: Healthcare
Phone: 212 220 6633
Address:
One World Trade Center, Suite 8500, New York, United States
BigSqueezeComing
BigSqueezeComing Jun. 27 at 4:06 PM
$MNMD https://finance.yahoo.com/news/psychedelic-compass-pathways-achieves-primary-155018682.html
0 · Reply
CaseHunter
CaseHunter Jun. 27 at 3:51 PM
$MNMD
0 · Reply
twiggs462
twiggs462 Jun. 26 at 10:32 PM
$MNMD High Doses Of LSD Lead To ‘Greater Reductions In Depression’ Compared To Low Doses Of The Psychedelic, New Study Finds https://www.marijuanamoment.net/high-doses-of-lsd-lead-to-greater-reductions-in-depression-compared-to-low-doses-of-the-psychedelic-new-study-finds/ this aligns fully with mindmed
0 · Reply
hemlock17
hemlock17 Jun. 26 at 10:03 PM
$MNMD https://www.politico.com/news/2025/06/25/rfk-vaccine-donations-gavi-00422705 Dude is a fucking moron. Will sink this ship with pure stupidity. Look out.
0 · Reply
Shabbaman
Shabbaman Jun. 26 at 7:21 PM
$MNMD
0 · Reply
Bulltrader988
Bulltrader988 Jun. 26 at 7:12 PM
$MNMD added this basket today $CMPS $CYBN $MIRA 👃👀
0 · Reply
MichaelNaussCMT
MichaelNaussCMT Jun. 26 at 1:40 PM
$MNMD
0 · Reply
smile696
smile696 Jun. 26 at 1:15 PM
$MNMD https://www.marijuanamoment.net/house-votes-to-let-va-doctors-recommend-medical-marijuana-to-military-veterans-and-to-support-psychedelics-research/
0 · Reply
brbrown
brbrown Jun. 26 at 12:46 AM
$MNMD
0 · Reply
brbrown
brbrown Jun. 26 at 12:35 AM
$MNMD
0 · Reply
Latest News on MNMD
MindMed Announces New Employee Inducement Grants

Jun 9, 2025, 4:01 PM EDT - 17 days ago

MindMed Announces New Employee Inducement Grants

MindMed to Participate in June Investor Conferences

May 28, 2025, 7:00 AM EDT - 4 weeks ago

MindMed to Participate in June Investor Conferences

MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer

May 27, 2025, 7:00 AM EDT - 4 weeks ago

MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer

MindMed to Present at the 2025 RBC Capital Markets Global Healthcare Conference

May 13, 2025, 7:00 AM EDT - 6 weeks ago

MindMed to Present at the 2025 RBC Capital Markets Global Healthcare Conference

Mind Medicine (MindMed) Inc. (MNMD) Q1 2025 Earnings Call Transcript

May 8, 2025, 9:55 AM EDT - 7 weeks ago

Mind Medicine (MindMed) Inc. (MNMD) Q1 2025 Earnings Call Transcript

MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates

May 8, 2025, 7:00 AM EDT - 7 weeks ago

MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates

MindMed to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 24, 2025, 7:00 AM EDT - 2 months ago

MindMed to Report First Quarter 2025 Financial Results on May 8, 2025

MindMed Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD)

Apr 15, 2025, 7:00 AM EDT - 2 months ago

MindMed Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD)

MindMed Appoints Matt Wiley as Chief Commercial Officer

Mar 17, 2025, 7:00 AM EDT - 3 months ago

MindMed Appoints Matt Wiley as Chief Commercial Officer

Mind Medicine (MindMed) Inc. (MNMD) Q4 2024 Earnings Call Transcript

Mar 6, 2025, 12:10 PM EST - 4 months ago

Mind Medicine (MindMed) Inc. (MNMD) Q4 2024 Earnings Call Transcript

MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates

Mar 6, 2025, 7:00 AM EST - 4 months ago

MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates

MindMed to Present at Leerink's Global Healthcare Conference 2025

Mar 4, 2025, 7:00 AM EST - 4 months ago

MindMed to Present at Leerink's Global Healthcare Conference 2025

MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025

Feb 20, 2025, 7:00 AM EST - 4 months ago

MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025

MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Feb 4, 2025, 7:00 AM EST - 5 months ago

MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder

Jan 30, 2025, 7:00 AM EST - 5 months ago

MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder

MindMed to Be Added to the Nasdaq Biotechnology Index

Dec 19, 2024, 7:00 AM EST - 6 months ago

MindMed to Be Added to the Nasdaq Biotechnology Index

MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD)

Dec 16, 2024, 7:00 AM EST - 6 months ago

MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD)

MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress

Dec 11, 2024, 7:00 AM EST - 7 months ago

MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress

MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD)

Dec 5, 2024, 7:00 AM EST - 7 months ago

MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD)

MindMed Appoints Javier Muniz, M.D., as Vice President of Research and Development Strategy

Dec 3, 2024, 7:00 AM EST - 7 months ago

MindMed Appoints Javier Muniz, M.D., as Vice President of Research and Development Strategy

MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer

Nov 18, 2024, 7:00 AM EST - 7 months ago

MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer

MindMed to Participate in Upcoming Investor Conferences

Nov 13, 2024, 7:00 AM EST - 8 months ago

MindMed to Participate in Upcoming Investor Conferences

Mind Medicine: No News = Good News

Nov 10, 2024, 9:55 AM EST - 8 months ago

Mind Medicine: No News = Good News

Mind Medicine (MindMed) Inc. (MNMD) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 8:06 PM EST - 8 months ago

Mind Medicine (MindMed) Inc. (MNMD) Q3 2024 Earnings Call Transcript

MindMed Reports Third Quarter 2024 Financial Results and Business Updates

Nov 7, 2024, 4:01 PM EST - 8 months ago

MindMed Reports Third Quarter 2024 Financial Results and Business Updates

Mind Medicine: Two Pathways Created From One Pipeline Clinical Candidate

Nov 4, 2024, 4:04 PM EST - 8 months ago

Mind Medicine: Two Pathways Created From One Pipeline Clinical Candidate

MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business Update

Oct 24, 2024, 7:00 AM EDT - 8 months ago

MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business Update

MindMed to Participate in September Investor Conferences

Sep 4, 2024, 7:00 AM EDT - 10 months ago

MindMed to Participate in September Investor Conferences

Psychedelic Stocks: Focus On Their Cash

Aug 15, 2024, 12:30 PM EDT - 11 months ago

Psychedelic Stocks: Focus On Their Cash

CMPS

Mind Medicine (MindMed) Inc. (MNMD) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 11:21 AM EDT - 11 months ago

Mind Medicine (MindMed) Inc. (MNMD) Q2 2024 Earnings Call Transcript

MindMed readying Phase III trials for LSD therapy to treat anxiety

Aug 13, 2024, 7:44 AM EDT - 11 months ago

MindMed readying Phase III trials for LSD therapy to treat anxiety

Pacific Defense Announces US Army CMFF Program Team

Aug 13, 2024, 7:01 AM EDT - 11 months ago

Pacific Defense Announces US Army CMFF Program Team

MRNS

MindMed Reports Second Quarter 2024 Financial Results and Business Updates

Aug 13, 2024, 7:00 AM EDT - 11 months ago

MindMed Reports Second Quarter 2024 Financial Results and Business Updates

FDA Rejection of MDMA Therapy Isn't End of Psychedelic-Drug Candidates

Aug 12, 2024, 12:47 PM EDT - 11 months ago

FDA Rejection of MDMA Therapy Isn't End of Psychedelic-Drug Candidates

Psychedelic drug contender stocks drop after FDA rejects MDMA treatment

Aug 12, 2024, 12:12 PM EDT - 11 months ago

Psychedelic drug contender stocks drop after FDA rejects MDMA treatment

ATAI CMPS CYBN

Mind Medicine (MindMed) Inc. Announces Pricing of Public Offering

Aug 9, 2024, 8:44 AM EDT - 11 months ago

Mind Medicine (MindMed) Inc. Announces Pricing of Public Offering

Mind Medicine (MindMed) Inc. Announces Proposed Public Offering

Aug 9, 2024, 6:00 AM EDT - 11 months ago

Mind Medicine (MindMed) Inc. Announces Proposed Public Offering

MindMed And Other Psychedelic Stocks Brace For FDA's Decision On MDMA Therapy

Aug 7, 2024, 2:29 PM EDT - 11 months ago

MindMed And Other Psychedelic Stocks Brace For FDA's Decision On MDMA Therapy

MindMed to Present at Canaccord Genuity's 44th Annual Growth Conference

Aug 6, 2024, 4:01 PM EDT - 11 months ago

MindMed to Present at Canaccord Genuity's 44th Annual Growth Conference

MindMed to Host Conference Call and Webcast to Discuss Second Quarter 2024 Financial Results and Provide Business Update

Aug 6, 2024, 7:00 AM EDT - 11 months ago

MindMed to Host Conference Call and Webcast to Discuss Second Quarter 2024 Financial Results and Provide Business Update

MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer

Jul 29, 2024, 7:00 AM EDT - 11 months ago

MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer

MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT)

Jul 17, 2024, 7:00 AM EDT - 1 year ago

MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT)

MindMed to be Included in Russell 2000® and Russell 3000® Indexes

Jun 28, 2024, 7:00 AM EDT - 1 year ago

MindMed to be Included in Russell 2000® and Russell 3000® Indexes

MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Jun 21, 2024, 7:00 AM EDT - 1 year ago

MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD)

Jun 20, 2024, 7:00 AM EDT - 1 year ago

MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD)

MindMed: Despite MDMA Setback, Still Hope In Light Of Differentiating Factors

Jun 5, 2024, 11:46 AM EDT - 1 year ago

MindMed: Despite MDMA Setback, Still Hope In Light Of Differentiating Factors

MindMed to Participate in June Conferences

May 28, 2024, 7:00 AM EDT - 1 year ago

MindMed to Participate in June Conferences

Psychedelics Closer To Commercialization; Compass Far And Away The Leader

May 23, 2024, 12:15 PM EDT - 1 year ago

Psychedelics Closer To Commercialization; Compass Far And Away The Leader

CMPS

MindMed to Participate at May Investor Conferences

May 9, 2024, 4:01 PM EDT - 1 year ago

MindMed to Participate at May Investor Conferences

New Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the US

May 9, 2024, 8:00 AM EDT - 1 year ago

New Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the US

BigSqueezeComing
BigSqueezeComing Jun. 27 at 4:06 PM
$MNMD https://finance.yahoo.com/news/psychedelic-compass-pathways-achieves-primary-155018682.html
0 · Reply
CaseHunter
CaseHunter Jun. 27 at 3:51 PM
$MNMD
0 · Reply
twiggs462
twiggs462 Jun. 26 at 10:32 PM
$MNMD High Doses Of LSD Lead To ‘Greater Reductions In Depression’ Compared To Low Doses Of The Psychedelic, New Study Finds https://www.marijuanamoment.net/high-doses-of-lsd-lead-to-greater-reductions-in-depression-compared-to-low-doses-of-the-psychedelic-new-study-finds/ this aligns fully with mindmed
0 · Reply
hemlock17
hemlock17 Jun. 26 at 10:03 PM
$MNMD https://www.politico.com/news/2025/06/25/rfk-vaccine-donations-gavi-00422705 Dude is a fucking moron. Will sink this ship with pure stupidity. Look out.
0 · Reply
Shabbaman
Shabbaman Jun. 26 at 7:21 PM
$MNMD
0 · Reply
Bulltrader988
Bulltrader988 Jun. 26 at 7:12 PM
$MNMD added this basket today $CMPS $CYBN $MIRA 👃👀
0 · Reply
MichaelNaussCMT
MichaelNaussCMT Jun. 26 at 1:40 PM
$MNMD
0 · Reply
smile696
smile696 Jun. 26 at 1:15 PM
$MNMD https://www.marijuanamoment.net/house-votes-to-let-va-doctors-recommend-medical-marijuana-to-military-veterans-and-to-support-psychedelics-research/
0 · Reply
brbrown
brbrown Jun. 26 at 12:46 AM
$MNMD
0 · Reply
brbrown
brbrown Jun. 26 at 12:35 AM
$MNMD
0 · Reply
MichaelNaussCMT
MichaelNaussCMT Jun. 25 at 11:36 PM
$MNMD 50 at least
2 · Reply
twiggs462
twiggs462 Jun. 25 at 11:28 PM
$MNMD Should point out that Mike Davis is connected to Rob Barrow (MindMed CEO) and both worked at Usona... now that Davis is deputy director of FDA CEDR - I have a hunch MindMed's chances, at the very least, of very transparent and consistent discussions are very very high. Bullish MindMed.
0 · Reply
BankOnTheFuture
BankOnTheFuture Jun. 25 at 11:21 PM
$CMPS $CYBN $ATAI $MNMD HR3944 PASSED. "Department of Veterans Affairs to direct the Department to evaluate and make recommendations on changes that would need to be made to its existing healthcare infrastructure to integrate approved psychedelic therapies into veterans' care options for conditions such as PTSD and substance use disorders. " https://democraticwhip.house.gov/floor-resources/amendment-tracker/hr-3944-military-construction-veterans-affairs-and-related-agencies-appropriations-act-2026
0 · Reply
MichaelNaussCMT
MichaelNaussCMT Jun. 25 at 9:55 PM
$MNMD 50
0 · Reply
zcurrency
zcurrency Jun. 25 at 8:20 PM
$MNMD
0 · Reply
Bulltrader988
Bulltrader988 Jun. 25 at 6:42 PM
$MNMD with $CMPS $CYBN $MIRA 👃👀 https://x.com/OracleNYSE/status/1937937998558986705?t=mwfWeATSjofS0Q06o4yNEw&s=19
0 · Reply
BobbyCucumber
BobbyCucumber Jun. 25 at 6:24 PM
$MNMD CMPS selloff a huge over reaction, whole sector bouncing back nicely, time to add....
0 · Reply
wemmmm
wemmmm Jun. 25 at 6:18 PM
$MNMD going to 10 https://x.com/oraclenyse/status/1937937998558986705?s=46&t=PEWZbEPDlfCXIpORNZ-ynQ
0 · Reply
twiggs462
twiggs462 Jun. 25 at 4:31 PM
$CMPS $ATAI $MNMD $CYBN
0 · Reply
UncleJudd
UncleJudd Jun. 25 at 2:28 PM
$CMPS $ATAI $MNMD $CYBN https://www.biospace.com/fda/fda-names-psychedelic-proponent-as-cder-deputy-director-top-spot-remains-open
0 · Reply
GreenEnergy2022
GreenEnergy2022 Jun. 25 at 2:14 PM
$MNMD Might add at 5 if it gets there
0 · Reply
terrasan
terrasan Jun. 25 at 2:11 PM
$MNMD Looks like the tutes are wanting to load up at the expense of the paper hands and gaping v's.
0 · Reply